SCHEMBL8230653

SCHEMBL8230653

CC1C(=O)O[C@@H]1C(=O)NCCCC(NC(=O)[C@H](C)NC(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB5 P28074 12/20 0.53
▸ FASN P49327 2/20 0.53
▸ PSMB1 P20618 5/20 0.46
▸ PSMB2 P49721 3/20 0.46
▸ PSMB8 P28062 3/20 0.46
▸ PSMB9 P28065 3/20 0.46
▸ PSMB11 A5LHX3 2/20 0.46
▸ PSMD11 O00231 2/20 0.46
▸ PSMD12 O00232 2/20 0.46
▸ PSMD14 O00487 2/20 0.46
▸ PSMA7 O14818 2/20 0.46
▸ PSMD3 O43242 2/20 0.46
▸ PSMC3 P17980 2/20 0.46
▸ PSMA1 P25786 2/20 0.46
▸ PSMA2 P25787 2/20 0.46
▸ PSMA3 P25788 2/20 0.46
▸ PSMA4 P25789 2/20 0.46
▸ PSMA5 P28066 2/20 0.46
▸ PSMB4 P28070 2/20 0.46
▸ PSMB6 P28072 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8225282 1.00 PSMB5 (0.53) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL10035697 1.00 PSMB5 (0.53) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL10035699 1.00 PSMB5 (0.53) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL10066901 0.89 PSMB5 (0.47) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL10067255 0.89 PSMB5 (0.47) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL10035734 0.89 PSMB5 (0.62) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL8231027 0.89 PSMB5 (0.62) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL10035732 0.89 PSMB5 (0.62) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL8232847 0.89 PSMB5 (0.62) PSMB5FASNPSMB1PSMB2PSMB8
SCHEMBL10035719 0.88 PSMB5 (0.61) PSMB5FASNPSMB1PSMB2PSMB8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008006113-A2 NOVEL BELACTOSIN DERIVATIVES AS THERAPEUTIC AGENTS/BIOLOGICAL PROBES AND THEIR SYNTHESIS THE TEXAS A & M UNIVERSITY SYSTEM (US) 2008-01-10 — — WO disclosed
Send feedback